TEOSYAL® RHA1

TEOSYAL® RHA1 is a wrinkle filler product based on hyaluronic acid designed to support the skin in every move, while helping to preserve the vitality and softness of the face. This Teosyal® formulation is designed specifically to treat superficial and fine wrinkles. The product contains lidocaine, a powerful anaesthetic, for a more comfortable injection.

TEOSYAL® RHA1 creates a volume that corrects fine lines.

• Preserves skin vitality and softness
• Fills superficial and fine wrinkles
• To hydrate the skin
• Particularly suitable for perioral wrinkles
• Mixture of 15 mg/ml cross-linked and non-cross-linked HA
• 0.3% lidocaine
• 1.9% MoD*

Teosyal® RHA1: Natural-Looking Results for Fine Lines

Struggling with fine lines and wrinkles? Teosyal® might be the answer. This injectable filler uses special hyaluronic acid (HA), a substance naturally found in your skin. Here’s what makes it unique:

• Natural and Flexible: Unlike some fillers, Teosyal® uses non-modified HA. This allows your facial expressions to shine through while still providing support and smoothing out fine lines.
• Comfortable Treatment: The inclusion of lidocaine, a numbing agent, helps minimize discomfort during injection.
• Safe and Effective: This Teosyal Formulation is made with stabilized HA that’s not derived from animals.

With Teosyal®, you can achieve natural-looking results and maintain the vitality and softness of your skin.

• Injection into the middermis with a 30G needle

Contraindications:

• Advise your doctor in case of known hypersensitivity to Hyaluronic Acid, with a history of severe allergy or anaphylactic shock.
• TEOSYAL® RHA1 contains 0.3% of lidocaine. Advise your doctor for guidance in case of:
  • Known hypersensitivity, allergy to lidocaine and/or local anesthetics of the amide type;
  • Athletes: lidocaine can induce a positive reaction to anti-doping tests;
  • Heart diseases and/or patient under treatment for heart disease (beta-blockers).
• TEOSYAL® RHA 1 must not be used:
  • for injections other than intradermal,
  • in combination with peeling, laser or ultrasound-based treatments,
  • if the patient has cutaneous disorders, inflammation or infection at or near the treatment site,
  • in the case of patients having a known hypersensitivity to hyaluronic acid, with a history of severe allergy or anaphylactic shock,
  • in the case of known hypersensitivity to lidocaine and/or amide local anaesthetic agents,
  • in the case of patients having a known hypersensitivity to one of the excipients of the supplemented phosphate buffer,
  • in the case of patients with autoimmune diseases,
  • in the case of patients with cardiac diseases and/or undergoing treatment for heart diseases (beta blockers),
  • in the case of patients with hepatocellular insufficiency and/or undergoing treatment for liver disease,
  • in pregnancy, breastfeeding mothers, or in children.

After-care:

• The patient is advised to gently massage the area daily for at least 72 hours with the POST PROCEDURE cream to prevent a lymphatic lump from forming.